(Q48706861)

14 February 2018

review article

1 reference

title

The elevated T-maze as an experimental model of anxiety. (English)

1 reference

14 February 2018

author name string

Graeff FG

series ordinal

1

1 reference

14 February 2018

Netto CF

series ordinal

2

1 reference

14 February 2018

Zangrossi H Jr

series ordinal

3

1 reference

14 February 2018

publication date

1 January 1998

1 reference

14 February 2018

Neuroscience & Biobehavioral Reviews

published in

1 reference

14 February 2018

volume

23

1 reference

14 February 2018

issue

2

1 reference

14 February 2018

page(s)

237-246

1 reference

14 February 2018

Lasting effects on rodent anxiety of a single exposure to a cat.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

5-HT and mechanisms of defence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea hydrochloride: the first selective 5-HT1C receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Treatment of spontaneous panic attacks with chlomipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Role of 5-HT in stress, anxiety, and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Behavioural profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Effect of chlorimipramine and maprotiline on experimental anxiety in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

5HT drugs in animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Serotonin and anxiety revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Observational conditioning of snake fear in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

The relation between fear induced by novel stimulation and exploratory drive

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

The septum and amygdala differentially mediate the anxiolytic effects of benzodiazepines.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Behavioral effects of the putative anxiolytic (+/-)-1-(2,5-dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2) in rats and mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Controlling panic attacks with fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Fenfluramine provocation of anxiety in patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Anxiogenic stimuli in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Anxiolytic effects of serotonergic interventions in the shock-probe burying test and the elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

The elevated T-maze: a new animal model of anxiety and memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Behavior of Light- and Dark-Reared Rats on a Visual Cliff

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Chlordiazepoxide reduces the generalised anxiety, but not the direct responses, of rats exposed to cat odor

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

Habituation and generalization of phobic responses to cat odor.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900024-4

7 January 2021

10.1016/S0149-7634(98)00024-4

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018